These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15598693)

  • 1. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.
    Angelico F; Del Ben M; Conti R; Francioso S; Feole K; Fiorello S; Cavallo MG; Zalunardo B; Lirussi F; Alessandri C; Violi F
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1578-82. PubMed ID: 15598693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity.
    Wasada T; Kasahara T; Wada J; Jimba S; Fujimaki R; Nakagami T; Iwamoto Y
    Metabolism; 2008 Jul; 57(7):980-5. PubMed ID: 18555841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic conditions of fatty liver in non-diabetic obese women.
    Kantarceken B; Cetinkaya A; Inanc Tolun F; Yerhan H; Citirik C; Buyukbese MA
    J Endocrinol Invest; 2007 Sep; 30(8):672-6. PubMed ID: 17923799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome.
    Mallea-Gil MS; Ballarino MC; Spiraquis A; Iriarte M; Kura M; Gimenez S; Oneto A; Guitelman M; Machado R; Miguel CM
    Acta Gastroenterol Latinoam; 2012 Mar; 42(1):20-6. PubMed ID: 22616493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol consumption is inversely correlated with insulin resistance, independent of metabolic syndrome factors and fatty liver diseases.
    Gunji T; Matsuhashi N; Sato H; Iijima K; Fujibayashi K; Okumura M; Sasabe N; Urabe A
    J Clin Gastroenterol; 2011 Oct; 45(9):808-13. PubMed ID: 21694610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
    Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
    Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society.
    Soresi M; Noto D; Cefalù AB; Martini S; Vigna GB; Fonda M; Manzato E; Cattin L; Fellin R; Averna MR; Notarbartolo A;
    Acta Diabetol; 2013 Apr; 50(2):241-9. PubMed ID: 22684314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.
    Jung CH; Lee WJ; Hwang JY; Yu JH; Shin MS; Lee MJ; Jang JE; Leem J; Park JY; Kim HK
    Diabet Med; 2013 Apr; 30(4):428-35. PubMed ID: 23278318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease.
    Casoinic F; Sâmpelean D; Badău C
    Rom J Intern Med; 2006; 44(4):419-26. PubMed ID: 18386618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver steatosis in obese prepubertal children: a possible role of insulin resistance.
    D'Adamo E; Impicciatore M; Capanna R; Loredana Marcovecchio M; Masuccio FG; Chiarelli F; Mohn AA
    Obesity (Silver Spring); 2008 Mar; 16(3):677-83. PubMed ID: 18239582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases.
    Angelico F; Del Ben M; Conti R; Francioso S; Feole K; Maccioni D; Antonini TM; Alessandri C
    J Gastroenterol Hepatol; 2003 May; 18(5):588-94. PubMed ID: 12702052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty liver and the metabolic syndrome among Shanghai adults.
    Fan JG; Zhu J; Li XJ; Chen L; Lu YS; Li L; Dai F; Li F; Chen SY
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1825-32. PubMed ID: 16336439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease.
    Tsai CH; Li TC; Lin CC
    South Med J; 2008 Sep; 101(9):900-5. PubMed ID: 18708987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
    Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.